Donor-specific antibodies in lung transplantation

Area of Science:

• Immunology
• Transplantation Medicine
• Biomarker Discovery

Background:

• Donor-specific antibodies (DSA) are a significant risk factor for poor outcomes in lung transplantation.
• Humoral responses in lung transplant recipients have been a focus of intense research.

Purpose of the Study:

• To review current understanding of humoral responses post-lung transplantation.
• To summarize recent findings and identify future research areas.

Main Methods:

• Literature review of recent studies on humoral responses in lung transplantation.
• Analysis of biomarkers and associated factors for antibody-mediated rejection.

Main Results:

• Donor-derived cell-free DNA (ddcfDNA) is a promising biomarker for predicting antibody-mediated rejection (AMR), showing elevated levels before clinical dysfunction.
• Pseudomonas aeruginosa infection is independently associated with DSA development, suggesting a link between innate and alloimmune responses.

Conclusions:

• Despite slow progress, research into humoral responses is crucial for improving lung transplant outcomes.
• Identifying biomarkers like ddcfDNA and understanding infection-related alloimmunity are key areas for future investigation.